|
|
Article: Unmet Needs in Asthma Therapy Market Boosts Demand for New Generation Drugs.
- Article from:
- PR Newswire
- Article date:
- March 24, 2003
CopyrightCOPYRIGHT 2003 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
SAN JOSE, Calif. -- SAN JOSE, Calif., March 24 /PRNewswire/ -- The growing prevalence of asthma coupled with the need for more effective, safer and convenient drugs has created a high-demand market eager to adopt new generation asthma therapies. The unprecedented success of GlaxoSmithKline's Advair, the first drug to combine a bronchodilator with a corticosteroid in the same inhaler device, has changed the landscape of the U.S. asthma therapies market. As physicians become more comfortable with the long-term safety of Advair, few patient groups will remain off limits for this drug, which is already being used more widely than originally anticipated.
New ...
Related newspaper, magazine, and journal articles:
|
|
Article: Concerns raised over 'dangerously high' doses of asthma ...
The Scotsman;
May 5, 2006 ;
668 words
...EXPERTS are warning that thousands of asthma patients may be taking potentially dangerous levels of drugs in efforts to control their condition. Asthma sufferers are prescribed inhaled steroids in increasing doses until the illness is under control. However, a researcher at Aberdeen University has
|
|